Diagnostic kit for in-vitro quantitative determination of GP73 (Golgi Protein 73) with latex-enhanced immunoturbidimetry
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- ENZYMAKER LABCHANGZHOU CO LTD
- Publication Date
- 2016-01-06
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a kit for measuring the content of GP73 (Golgi glycoprotein-73, GolgiProtein73) in human serum by using a latex-enhanced immune turbidimetric method, which belongs to the field of in vitro medical immunodiagnosis. Background technique
[0002] GP73 (Golgi Glycoprotein-73, GolgiProtein73) is also known as type II Golgi membrane protein, Type II Golgimembraneprotein, Golph2), because Golph2 polyclonal antiserum can specifically recognize protein molecules with a size of 7.3×104 in human epithelial cell lysates, Therefore, this protein is also called GP73. GP73 is a transmembrane protein present in the Golgi apparatus with a molecular weight of 45KDa. However, GP73 undergoes a large amount of glycosylation in serum, and its molecular weight is about 73KDa in serum detection. Since GP73 is rich in acidic amino acids (5.5% aspartic acid, 12.2% glutamic acid), its isoelectric point PI = 4.72. GP73 is strongly hydrophilic but has hy...